A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL.
The file type is
TET3 expression associates with survival in triple negative breast cancer
We mined published microarray data (1) to understand the most significant gene expression differences in the tumors of triple negative breast cancer patients based on survival at time of analysis: dead or alive. We observed transcriptome-wide differential expression of TET3 when comparing the primary tumors of triple negative breast cancer patients dead or alive. TET3 mRNA was present at significantly lower quantities in the tumors of TNBC patients alive. Importantly, TET3 expression wasdoi:10.31219/osf.io/qxhaf fatcat:th2uoeifvbbhvdnik5omekyowa